Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Lemeer

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Molecular & Cellular Proteomics : MCP|August 10, 2014
Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomicsDominic Helm, Johannes P C Vissers, Christopher J Hughes, et al.
Cellular and Molecular Life Sciences : CMLS|November 3, 2016
Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapyRuud Weijer, Séverine Clavier, Esther A Zaal, et al.
Cell|November 15, 2016
EGFR Dynamics Change during Activation in Native Membranes as Revealed by NMRMohammed Kaplan, Siddarth Narasimhan, Cecilia de Heus, et al.
Nature|May 30, 2014
Mass-spectrometry-based draft of the human proteomeMathias Wilhelm, Judith Schlegl, Hannes Hahne, et al.
Molecular Cell|February 11, 2021
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myelomaMichael Heider, Ruth Eichner, Jacob Stroh, et al.
Nature Methods|April 15, 2020
Meltome atlas-thermal proteome stability across the tree of lifeAnna Jarzab, Nils Kurzawa, Thomas Hopf, et al.
Nature Medicine|June 14, 2016
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicityRuth Eichner, Michael Heider, Vanesa Fernández-Sáiz, et al.
Nature Medicine|November 25, 2014
Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesisUrsula Baumann, Vanesa Fernández-Sáiz, Martina Rudelius, et al.
Breast Cancer Research : BCR|March 31, 2021
RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancerAdrián Sanz-Moreno, Sonia Palomeras, Kim Pedersen, et al.
Cancer Cell|June 13, 2023
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicityClaire Vennin, Chiara M Cattaneo, Leontien Bosch, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Molecular & Cellular Proteomics : MCP|August 10, 2014
Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomicsDominic Helm, Johannes P C Vissers, Christopher J Hughes, et al.
Cellular and Molecular Life Sciences : CMLS|November 3, 2016
Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapyRuud Weijer, Séverine Clavier, Esther A Zaal, et al.
Cell|November 15, 2016
EGFR Dynamics Change during Activation in Native Membranes as Revealed by NMRMohammed Kaplan, Siddarth Narasimhan, Cecilia de Heus, et al.
Nature|May 30, 2014
Mass-spectrometry-based draft of the human proteomeMathias Wilhelm, Judith Schlegl, Hannes Hahne, et al.
Molecular Cell|February 11, 2021
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myelomaMichael Heider, Ruth Eichner, Jacob Stroh, et al.
Nature Methods|April 15, 2020
Meltome atlas-thermal proteome stability across the tree of lifeAnna Jarzab, Nils Kurzawa, Thomas Hopf, et al.
Nature Medicine|June 14, 2016
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicityRuth Eichner, Michael Heider, Vanesa Fernández-Sáiz, et al.
Nature Medicine|November 25, 2014
Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesisUrsula Baumann, Vanesa Fernández-Sáiz, Martina Rudelius, et al.
Breast Cancer Research : BCR|March 31, 2021
RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancerAdrián Sanz-Moreno, Sonia Palomeras, Kim Pedersen, et al.
Cancer Cell|June 13, 2023
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicityClaire Vennin, Chiara M Cattaneo, Leontien Bosch, et al.
Pageof 7